ClinicalTrials.gg

Program

DLBS3233

Its studies are mostly in Diabetes Mellitus, Type 2 · Polycystic Ovary Syndrome · Prediabetic State, led by Dexa Medica Group.

Furthest: phase 3, since Nov 11, 20116 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Dexa Medica Group60 open or runningphase 3since Nov 11, 2011Nov 11, 2011none ahead

Also a collaborator on its studies: pt-equilab-international.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 11, 2011First study: phase 3 study in Type-2 Diabetes MellitusFirst studyNCT01472614 · 54 enrolled · Indonesia
  2. Feb 9, 2012Phase 3 study in Diabetes Mellitus, Type 2NCT01531933 · 80 enrolled · Indonesia
  3. Jul 18, 2012Phase 3 study in Type-2-diabetes MellitusNCT01645332 · 104 enrolled · Indonesia
  4. Nov 21, 2012Phase 3 study in Polycystic Ovary SyndromeNCT01733459 · 124 enrolled · Indonesia
  5. Nov 26, 2013Phase 3 study in Polycystic Ovary SyndromeNCT01999686 · 186 enrolled · Indonesia
  6. Nov 9, 2026Phase 3 study in Prediabetic StateNCT07937449 · 120 enrolled · Indonesia

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07937449Prediabetic State · Indonesia3CompletedOct 15, 2026120
NCT01999686Polycystic Ovary Syndrome · Indonesia3CompletedFeb 2019186
NCT01733459Polycystic Ovary Syndrome · Indonesia3CompletedApr 2018124
NCT01645332Type-2-diabetes Mellitus · Indonesia3CompletedAug 2014104
NCT01531933Diabetes Mellitus, Type 2 · Indonesia3CompletedJul 201280
NCT01472614Type-2 Diabetes Mellitus · Indonesia3CompletedJan 201354

How it is read

Names in the registry

  • “DLBS3233”, 6 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.